Genotype and Hormonal Phenotype in Nonclassical 21-Hydroxylase Deficiency*
- 1 January 1987
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 64 (1) , 86-91
- https://doi.org/10.1210/jcem-64-1-86
Abstract
In nonclassical steroid 21-hydroxylase deficiency, the genotype may be represented as a homozygous mild (nonclassicai) form of the 21-hydroxylase defect or as a compound heterozygote, with one severe (classical) and one mild (nonclassical) 21-hydroxylase deficiency allele. We examined hormone levels in patients with nonclassical 21-hydroxylase deficiency in whom pedigree analysis and/or HLA linkage disequilibrium allowed unequivocal identification of the respective haplotypes as either classical or nonclassical. The results indicated that compound heterozygotes (21-OH defsevere/21-OH defmild) have an ACTH-stimulated 17-hydroxyprogesterone (17-OHP) response significantly greater than that of mild homozy-gotes (21-OH dermild/21-OH defmild): at 60 min, 8,131 ± 4,205 (± SD) (n = 17) vs. 4,468 ± 2,123 ng/dl (n = 31) for the respective groups (P < 0.01); at 360 min, 11,067 ± 5,582 (n = 17) vs. 5746 ± 1565 (n = 8, P < 0.01). Since serum cortisol levels were the same in both groups, the ratio of 17-OHP to cortisol was higher in the former group. Sixty minute ACTH-stimulated serum Δ4-androstenedione levels also were significantly higher in compound heterozygotes than in mild homozygotes. Serum dehydro-epiandrosterone and its sulfate were not signicantly different between the two groups. Notably, compound heterozygotes were no more likely to have signs of androgen excess than were homozygotes for the mild gene defect. Stimulated levels of serum 17-OHP, 17-OHP/cortisol, Δ4-androstenedione and dehydroepiandrosterone and its sulfate did not differ significantly between heterozygotes for the classical (21-OH defsevere/21-OHnormal) and nonclassical (21-OH defmild/21-OHnormal) 21-hydroxylas e deficiency alleles. Thus, the presence of a single normal 21-hydroxylase allele is sufficient to obscure the difference between a severe and a mild 21-hydroxy-lase deficiency allele on the opposite haplotype. We conclude that the compound heterozygous patients as a group have a significantly higher response of 21-hydroxylase precursors to ACTH stimulation than do patients with the homozygous mild 21-hydroxylase deficiency state.Keywords
This publication has 20 references indexed in Scilit:
- Cryptic 21-Hydroxylase Deficiency in Families of Patients with Classical Congenital Adrenal Hyperplasia*Journal of Clinical Endocrinology & Metabolism, 1980
- The Attenuated Form of Congenital Adrenal Hyperplasia as an Allelic Form of 21-Hydroxylase Deficiency*Journal of Clinical Endocrinology & Metabolism, 1980
- Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: A new Allele at the 21-hydroxylase locusHuman Immunology, 1980
- An Attenuated Form of Congenital Virilizing Adrenal Hyperplasia*Journal of Clinical Endocrinology & Metabolism, 1979
- Serum Androgens as a Continuing Index of Adequacy of Treatment of Congenital Adrenal Hyperplasia*Journal of Clinical Endocrinology & Metabolism, 1978
- CLOSE GENETIC LINKAGE BETWEEN HLA AND CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY)The Lancet, 1977
- Microfilter Paper Method for 17α-Hydroxyprogesterone Radioimmunoassay: Its Application for Rapid Screening for Congenital Adrenal HyperplasiaJournal of Clinical Endocrinology & Metabolism, 1977
- The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasiaThe Journal of Pediatrics, 1977
- Partial 11- and 21-hydroxylase deficiencies in hirsute womenAmerican Journal of Obstetrics and Gynecology, 1977
- Studies on ACTH action in perfused bovine adrenals: The site of action of ACTH in corticosteroidogenesisArchives of Biochemistry and Biophysics, 1954